Hemo Organic (Small Cap - High Growth) Share Target 2024, 2025 To 2039
|
Hemo Organic Limited |
|||
|
Price: ₹12.90 | ||
| 52 Week Low: ₹6.44 52 Week High: ₹15.25 |
|||
| Market Capital: 3.75 Crore (Smallcap) | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Hemo Organic Share Price Target For 2024
- 1.1.1: Hemo Organic Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Hemo Organic Share Price Target For 2025
- 1.2.1: Hemo Organic Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Hemo Organic Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Hemo Organic Financial Performance
- 3.0.1: Is Hemo Organic A Good Buy For Long Term?
To predict the Hemo Organic's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Hemo Organic Share Price Target For 2024
The line chart displays the monthly closing prices of Hemo Organic with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Hemo Organic shares in 2024, see the table below.
Hemo Organic Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 13.8 (+6.97%) | Price Action: May 2018 Low |
| 2024 Target 2 | 13.65 (+5.81%) | Price Action: Sep 2017 Low |
| 2024 Target 1 | 13.49 (+4.57%) | Price Action: Jan 2021 Low |
| Current Price | 12.90 | Hemo Organic's share price as of 26 Dec 2024 |
| Stop Loss 1 | 12.6 (-2.33%) | Price Action: Apr 2024 High |
| Stop Loss 2 | 12.46 (-3.42%) | Price Action: 22 Oct 2024 Low |
| Stop Loss 3 | 12.29 (-4.73%) | Fibonacci Retracement Level 38.20% |
Short-Term Technical Outlook
Current Technical Position: Hemo Organic is showing bullish momentum with price above both 25-day and 50-day moving averages.
Key Technical Level: The 25-day moving average at ₹11.49 serves as the nearest technical reference point.
Historical Returns: 3-month: +5.82% | 6-month: +11.5% | 1-year: +71.77%
Hemo Organic Share Price Target For 2025
The line chart displays the monthly closing prices of Hemo Organic with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Hemo Organic shares in 2025, see the table below.
Hemo Organic Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 19.17 (+48.6%) | Price Action: Chart |
| 2025 Target 2 | 18.81 (+45.81%) | Price Action: Chart |
| 2025 Target 1 | 18.62 (+44.34%) | Fibonacci Extension Level 64.90% |
| Current Price | 12.90 | Hemo Organic's share price as of 26 Dec 2024 |
| Stop Loss 1 | 11.59 (-10.16%) | Price Action: 15 Apr 2024 Low |
| Stop Loss 2 | 11.46 (-11.17%) | Price Action: Apr 2023 High |
| Stop Loss 3 | 11.34 (-12.1%) | Price Action: 07 Aug 2024 High |
Long-Term Technical Outlook
52-Week Range Analysis: Hemo Organic is currently trading at 73.3% of its 52-week range (₹6.44 - ₹15.25).
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: +71.77% | 3-year: +66.02% | 5-year: -15.13%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Hemo Organic Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹12.90 | ||
| 2024 | ₹12.21 | -5.34% | ₹12.39 |
| 2025 | ₹13.53 | +10.81% | ₹14.32 |
| 2026 | ₹16.13 | +19.21% | ₹16.40 |
| 2027 | ₹19.15 | +18.72% | ₹19.44 |
| 2028 | ₹20.70 | +8.09% | ₹21.01 |
| 2029 | ₹22.91 | +10.67% | ₹23.25 |
| 2030 | ₹23.61 | +3.05% | ₹25.25 |
| 2031 | ₹26.59 | +12.62% | ₹27.39 |
| 2032 | ₹30.14 | +13.35% | ₹30.59 |
| 2033 | ₹31.36 | +4.04% | ₹31.92 |
| 2034 | ₹33.60 | +7.14% | ₹34.10 |
| 2035 | ₹33.69 | +0.26% | ₹36.19 |
| 2036 | ₹37.05 | +9.97% | ₹38.38 |
| 2037 | ₹41.13 | +11.01% | ₹41.75 |
| 2038 | ₹42.02 | +2.16% | ₹42.89 |
| 2039 | ₹43.88 | +4.42% | ₹44.54 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Hemo Organic Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 3.75 Crore | Market valuation of Hemo Organic's shares. |
| Revenue (TTM) | 2.24 Lakh | Total revenue generated by Hemo Organic over the past twelve months. |
| Net Income (TTM) | -26.41 Lakh | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | -1,088.83% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | +31.69% | Net income as a percentage of revenue, after all expenses. |
| Debt-to-Equity (D/E) Ratio |
-3.14 | Company's total debt divided by total shareholder equity. |
| Total Debt | 1.24 Crore | Sum of Hemo Organic's current & long-term financial obligations. |
Is Hemo Organic A Good Buy For Long Term?
Hemo Organic, a small-cap stock with a market capitalization of ₹3.75 crore, presents a high-risk, high-reward scenario. While recent returns (12-month: 72.88%, YTD: 44.34%) appear impressive, the company is currently loss-making (-₹26.41 lakh net profit on ₹2.24 lakh revenue in TTM), and carries significant debt (₹1.24 crore as of Q2 2024-25). Long-term prospects are uncertain, given its negative profit margin and poor 3- and 5-year returns (-27.25% and -42.95% respectively). Therefore, Hemo Organic is not a good buy for long-term investors. Further due diligence is strongly recommended.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
